| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $28.66B | $27.45B | $28.14B |
| YoY Revenue Growth % | +4.4% | -2.4% | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $8.93B | $7.43B | $6.41B |
| Operating Margin % | 31.2% | 27.1% | 22.8% |
| Net Income (GAAP) | $7.57B | $6.30B | $5.43B |
| EBITDA (Normalized) | $9.96B | $8.42B | $7.42B |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $7.97B | $11.35B | $8.39B |
| Capital Expenditures (CapEx) | $1.29B | $1.24B | $1.27B |
| Free Cash Flow (FCF) | $6.68B | $10.11B | $7.13B |
| FCF Margin % | 23.3% | 36.8% | 25.3% |
| Return on Invested Capital (ROIC %) | 2.6% | 2.2% | 16.1% |
| Cash & Short-Term Equivalents | — | — | — |
| Total Debt (Short + Long Term) | $282.01B | $278.68B | $12.16B |
| Total Stockholders' Equity | $65.19B | $58.58B | $24.94B |